Intellectual Property India Publishes Patent Application for 'Tyrosine Kinases Inhibitors And Uses Thereof' Filed by Great Novel Therapeutics Biotech & Medicals Corporation

MUMBAI, India, April 25 -- Intellectual Property India has published a patent application (202424077036 A) filed by Great Novel Therapeutics Biotech & Medicals Corporation, Taipei City, Taiwan, on Oct. 10, 2024, for 'tyrosine kinases inhibitors and uses thereof.'

Inventor(s) include Chen, Jia-Shiong; Yang, Mu-Hsuan; Chou, Cheng-Han; Wu, Yi-Hong; Chu, Sz-Hao; Chao, Ye-Su; and Chen, Chia-Nan.

The application for the patent was published on April 25, under issue no. 17/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure generally relates to novel multiple target inhibitor of tyrosine kinases (TKs) which can suppress angiogenesis, metastasis, oncogenesis, and/or immune regulation activities by...